Table 2.
Prevalence and characteristics of Advance Care Planning by GP (subgroup analyses for cancer, organ failure and multimorbidity patients)
| Prevalence of ACP (documentation) | Total (n = 119) |
Cancer (n = 55) |
Organ failure (n = 28) |
Multimorbidity (n = 36) |
P value |
|---|---|---|---|---|---|
| Prevalence (≥ 1 ACP item), n (%) | 77 (65) | 46 (84) | 16 (57) | 15 (42) | 0.000* |
| Characteristics of ACP |
Total (n = 77) |
Cancer (n = 46) |
Organ failure (n = 16) |
Multimorbidity (n = 15) |
P value |
| Extent | |||||
| Number of ACP items, median (25th -75th percentile, range) | 4 (2–7, 1–11) | 5 (2–7, 1–11) | 3,5 (2–6, 1–8) | 2 (1–5, 1–7) | 0.047** |
| Subclassification: | 0.222*** | ||||
| Low (1 or 2 items) | 29 (38) | 15 (33) | 6 (38) | 8 (53) | |
| Medium (3, 4 or 5 items) | 26 (34) | 14 (30) | 6 (38) | 6 (40) | |
| High (≥ 6 ACP items) | 22 (29) | 17 (37) | 4 (25) | 1 (7) | |
| Frequency | |||||
| Number of ACP conversations, median (25th–75th percentile, range) | 3 (1–4, 1–14) | 3 (2–5, 1–14) | 2 (1–3, 1–7) | 2 (1–3, 1–4) | 0.012** |
| Timing | |||||
| Time between first ACP conversation and death in days, median (25th–75th percentile, range) | 126 (30–316, 1–714) | 106 (22–307, 3–680) | 227 (39–395, 1–714) | 113 (52–320, 10–529) | 0.417** |
* Chi Square test, ** Kruskal Wallis test, *** Fisher’s Exact test